Marcel Frenkel

Co-Founder & CEO at Ten63 Therapeutics

Marcel Frenkel PhD is a biochemist with a background in computational protein and drug design, immunology and cancer cell biology. After losing his mother to pancreatic cancer, Marcel’s desire and vision on how to change the prognosis of patients suffering from cancer and other deadly diseases has brought a team of amazing scientists, engineers, and biotech experts together and become Ten63’s mission.

Links

Previous companies

University of Notre Dame logo

Org chart

Sign up to view 3 direct reports

Get started